Related Experiment Video

Updated: May 10, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

MicroRNAs in cardiovascular therapeutics

Gerasimos Siasos1, Dimitris Tousoulis, Panagiotis Tourikis

  • 11st Cardiology Department, University of Athens Medical School, Hippokration Hospital, Athens, Greece. gsiasos@med.uoa.gr

Current Topics in Medicinal Chemistry
|June 11, 2013
PubMed

Insights

MicroRNAs (miRNAs) are key regulators in cardiovascular disease development and progression. This review explores their role in various heart conditions and their therapeutic potential for future treatments.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Cardiology

Background:

  • MicroRNAs (miRNAs) are critical regulators of cardiovascular function.
  • miRNAs are implicated in the pathogenesis and progression of numerous cardiovascular diseases.
  • These include coronary artery disease, heart failure, stroke, hypertension, and arrhythmias.

Purpose of the Study:

  • To review the literature on the role of miRNAs in cardiovascular conditions.
  • To discuss the therapeutic potential of miRNAs in treating cardiovascular diseases.
  • To highlight future research directions in miRNA-based cardiovascular therapies.

Main Methods:

  • Literature review of existing research on miRNAs and cardiovascular diseases.
  • Analysis of pathophysiological pathways involving miRNAs in cardiovascular manifestations.
  • Exploration of current and future therapeutic strategies utilizing miRNAs.

Main Results:

  • miRNAs play a significant role in nearly all aspects of cardiovascular biology.
  • Specific miRNAs are involved in the development and progression of diverse cardiovascular pathologies.
  • Emerging evidence suggests miRNAs hold considerable therapeutic promise for cardiovascular diseases.

Conclusions:

  • miRNAs are integral to cardiovascular health and disease.
  • Targeting miRNAs offers a promising avenue for novel cardiovascular therapies.
  • Further research is warranted to fully elucidate miRNA functions and optimize therapeutic applications.

More Related Videos

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...